Richard N Williams - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Frontiers in Psychology|October 7, 2021

Agency: What Does It Mean to Be a Human Being?Richard N Williams, Edwin E Gantt, Lane Fischer

Drugs|July 24, 2015

Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval PathwayClaudia Filozof, Barry J Goldstein, Richard N Williams, et al.

The American Journal of Cardiology|August 27, 2020

Bretylium, a Class III Antiarrhythmic, Returns to the MarketMunveer Thind, Renee M Sullivan, Richard N Williams, et al.

Hepatology Communications|February 7, 2018

Clinical endpoints and adaptive clinical trials in precirrhotic nonalcoholic steatohepatitis: Facilitating development approaches for an emerging epidemicClaudia Filozof, Shein-Chung Chow, Lara Dimick-Santos, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Frontiers in Psychology|October 7, 2021

Agency: What Does It Mean to Be a Human Being?Richard N Williams, Edwin E Gantt, Lane Fischer

Drugs|July 24, 2015

Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval PathwayClaudia Filozof, Barry J Goldstein, Richard N Williams, et al.

The American Journal of Cardiology|August 27, 2020

Bretylium, a Class III Antiarrhythmic, Returns to the MarketMunveer Thind, Renee M Sullivan, Richard N Williams, et al.

Hepatology Communications|February 7, 2018

Clinical endpoints and adaptive clinical trials in precirrhotic nonalcoholic steatohepatitis: Facilitating development approaches for an emerging epidemicClaudia Filozof, Shein-Chung Chow, Lara Dimick-Santos, et al.

Pageof 1